logo
LTIMindtree posts steady Q1 with boost in Europe business

LTIMindtree posts steady Q1 with boost in Europe business

Mint17-07-2025
Bengaluru: LTIMindtree Ltd began the new fiscal year on solid footing, reporting revenue growth in line with expectations, led largely by clients in Europe and the retail segment.
India's sixth-largest IT services company on Thursday reported $1.15 billion in revenue for the June-ended quarter (Q1FY26), a 1.97% sequential rise. This matched the consensus estimate from a Bloomberg poll of 31 analysts.
Nearly three-fourths of its incremental revenue of $22 million came from clients based in Europe, which contributed $170 million in revenue. Retailers, grouped under the 'consumer' vertical, contributed the most to incremental revenue, with the segment bringing in $168 million, or 14.6% of overall revenue.
Management expressed optimism despite the challenging macroeconomic environment.
'While the macroeconomic environment remains challenging, I'm confident that our disciplined execution and unwavering client focus will continue to drive our performance,' chief executive Venu Lambu said in the company's earnings release.
The commentary echoed that of Tech Mahindra, where CEO Mohit Joshi had said 'the sentiment is still not conducive to significant discretionary investments' in sectors affected by tariffs.
LTIMindtree's performance stood out amid a weak demand environment for India's top IT exporters.
Wipro reported revenue of $2.59 billion for the April-June quarter, down 0.35% sequentially and 1.5% year-on-year. Its performance was broadly in line with the muted sequential growth posted by peers—Tata Consultancy Services ($7.42 billion, down 0.59%), HCL Technologies ($3.55 billion, up 1.34%), and Tech Mahindra ($1.56 billion, up 0.97%).
Infosys Ltd, India's second-largest IT outsourcer, will report its June-quarter results on 23 July.
Mint reported in May that LTIMindtree had bagged its largest deal to date—a seven-year, $450 million contract from Archer-Daniels-Midland Co (ADM), a Chicago-based food processing and commodities trading firm.
Two analysts who did not wish to be identified said the revenue bump in the June quarter likely stemmed from that large deal.
'It's most likely ADM that might have contributed to the increase in revenue,' said a Mumbai-based analyst on condition of anonymity.
Mint could not ascertain whether revenue from LTIMindtree's largest client contributed to the quarterly growth. The company did not hold a press conference following its results.
For Venu Lambu, who took over as chief executive on 31 May, the ADM deal is a shot in the arm and is expected to further support revenue growth. Analysts had anticipated the win would add to the company's total contract value. LTIMindtree does not disclose new order wins in its financials.
The company also posted a 12.6% sequential jump in net profit to $147 million, aided by lower tax expenses. Operating margins stood at 14.3%, up 50 basis points from the previous quarter.
Tech Mahindra reported 11.1% operating margins, a 60-basis-point sequential improvement.
Headcount fell by 418 to 83,889 during the quarter, tracking a similar trend at Tech Mahindra, which reduced its workforce by 214 to 148,517.
LTIMindtree's results set the tone for India's mid-tier IT firms with annual revenues between $1 billion and $5 billion. These companies not only grew faster than the top five IT majors last year, but also added more headcount.
Analysts expect this momentum to continue, with mid-sized firms likely to gain market share from their larger peers, thanks to more agile teams and fewer legacy operations, according to a Mint report dated 7 May.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Chennai Metrowater pilots robotic cleaning in sewage pumping stations to boost efficiency and workers' safety
Chennai Metrowater pilots robotic cleaning in sewage pumping stations to boost efficiency and workers' safety

The Hindu

time22 minutes ago

  • The Hindu

Chennai Metrowater pilots robotic cleaning in sewage pumping stations to boost efficiency and workers' safety

After deploying robots to clean sewer lines in some city zones, Chennai Metrowater is now piloting the use of robotic technology in sewage pumping stations in Thiruvanmiyur. The initiative aims to enhance operational safety and efficiency by minimising manual intervention. The water agency has already added Bandicoot Mobility, a robot that cleans maintenance holes of the sewer network, to remove clogged waste in sewer lines in zone 6 ( 9 (Teynampet) and 13 (Adyar). With robotic devices, which were developed by Genrobotics, a Kerala-based startup, helping to reduce clogging of lines for a year now, the water agency is exploring other innovative technologies to improve maintenance of sewer infrastructure. Officials of the Metrowater said an advanced robot with remote control unit and cameras, Wilboar, is being used to clean the sewage wells in Thiruvanmiyur sewage pumping station on a pilot basis. The robotic unit developed by Genrobotics is lowered into the wells that have a depth of up to 10 metre to remove the silt. With high-pressure water jets and grinders, the device grinds accumulated sludge into finer particles and clears them. This would eliminate the challenges in the use of conventional processes, improve efficiency of cleaning sewer wells and reduce complaints of sewage overflow in the pipelines. The Thiruvanmiyur sewage pumping station has a capacity to handle 15 million litres of sewage a day. Such robotic devices are already in use at Nellore, Andhra Pradesh and Thiruvananthapuram, Kerala, said officials. There are 375 sewage pumping stations in the city. Such robotic devices would be deployed in sewer well cleaning operations in other pumping stations following the success of the trial implementation. Rao, president, Chennai Metropolitan Water Supply and Sewerage Board Labourers Union, said it was a welcome initiative to ensure workers' safety and reduce manual intervention. Such efforts must be expanded to densely populated urban spaces and monitored for regular maintenance. Workers hired for sewer network maintenance should be redeployed to other roles. Nearly 2,850 labourers have been hired for sewer and water network maintenance in Chennai.

Logistics played key role in Operation Sindoor success, says Rajnath Singh
Logistics played key role in Operation Sindoor success, says Rajnath Singh

Economic Times

time22 minutes ago

  • Economic Times

Logistics played key role in Operation Sindoor success, says Rajnath Singh

Synopsis Defence Minister Rajnath Singh lauded Indian agencies for their seamless logistics management during Operation Sindoor, emphasizing its crucial role in the operation's success. He highlighted that modern warfare relies not only on weaponry but also on the timely delivery of resources. Seamless logistics management by Indian agencies-from mobilisation of the armed forces to delivering equipment at the right time and place-was a deciding factor in the success of Operation Sindoor, defence minister Rajnath Singh said on Sunday. ADVERTISEMENT In a virtual address at the convocation ceremony of Vadodara-based Gati Shakti Vishwavidyalaya (GSV), the minister said in the current era, wars are not just won by guns and bullets but by time-bound delivery of material, highlighting Op Sindoor as an example of excellent logistics management. "Whether it's soldiers fighting on the border or personnel engaged in disaster management, without coordination or proper management of resources, even the strongest of intentions weaken. Logistics is the power that transforms chaos into control. Power is measured not only by weapons, but also by timely resource management. Be it war, disaster or global pandemic, the nation which keeps its logistics chain strong is the most stable, secure and capable," he said. (You can now subscribe to our Economic Times WhatsApp channel) (Catch all the Business News, Breaking News, Budget 2025 Events and Latest News Updates on The Economic Times.) Subscribe to The Economic Times Prime and read the ET ePaper online. NEXT STORY

Cheaper cancer care therapy earns big bucks for pharma company
Cheaper cancer care therapy earns big bucks for pharma company

Economic Times

time22 minutes ago

  • Economic Times

Cheaper cancer care therapy earns big bucks for pharma company

India's cell and gene therapy pioneer ImmunoAct has turned profitable in its first full year of operations, a rare feat in the country's emerging startup landscape where research-based pharma enterprises encounter serious scale and cash flow challenges. ImmunoACT, in which Hyderabad-based drugmaker Laurus Labs has roughly 34% equity stake, saw revenues of ₹62 crore with a profit before tax of ₹12 crore in FY25, according to sources. The year before, ImmunoAct had revenues of ₹11 crore. Founded by immunologist Rahul Purwar in 2013, ImmunoACT was spun off from the department of bioengineering department of IIT Bombay in 2018. ImmunoACT's NexCAR19 is the first indigenously developed breakthrough cancer CAR-T (chimeric antigen receptor T-cell) therapy approved by India's central drug regulatory agency in October 2023. NexCAR19 was formally launched in India in April 2024 at a price ~90% cheaper than its US and European counterparts like Novartis and Gilead, making it far more affordable for India and low-and-middle income countries, on its potential approval. So far, the therapy has been infused in over 350 patients across 70 hospitals in India. In CAR-T treatment, the patient's immune cells are extracted and through a maze of re-engineering processes infused back to recognize and kill cancer cells, giving a longer remission to patients as compared to the conventional options like immunotherapy or bone marrow transplants. The therapy is used when all other options are CAR-T dose (one-and-done infusion) costs around ₹30 lakh, which was initially priced at ₹42 lakh, and is expected to see a further decline as demand picks ImmunoACT has recently appointed former managing director of Roche India V Simpson Immanuel as its strategic Purwar added, "We needed someone who understands not just the commercial landscape, but also the nuances of innovation, patient access, and global expansion." Earlier this year, Immuneel Therapeutics, backed by leading names like Kiran Mazumdar-Shaw and globally renowned oncologist Siddhartha Mukherjee secured approval for Qartemi, its cell therapy for adult B-cell non-Hodgkin Lymphoma, in India. Companies like Cipla, Dr Reddy's Labs and Bharat Biotech are investing heavily in new CAR-Ts. Globally, CAR-Ts are at the frontiers of a range of cancer treatments, attracting billions of dollars in investments from large drugmakers. The market for such therapies is expected to touch $134 billion by 2034 from around $10 billion at present.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store